Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company engaged in treating neuroinflammation with a current focus on CNS disorders and rare diseases. The company is headquartered in Palm Beach Gardens, Florida and currently employs 4 full-time employees. The company went IPO on 2024-12-03. The firm has developed a resveratrol platform product targeting the treatment of neuro-inflammation. Its product, JOTROL, has many potential indications of use for rare diseases, which primarily targets Mucopolysaccharidoses Type 1, Friedreich's Ataxia, and Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS). In the larger disease areas, it primarily targets Parkinson’s Disease and Mild Cognitive Impairment/early Alzheimer’s disease. The firm has designated the different indications with project numbers, JNS101 - JNS115. JOTROL is a micellar non-aqueous solution of resveratrol delivered in a soft gel capsule. Each capsule includes 100mg of resveratrol. The company has a worldwide license from Aquanova AG, the patent holder of micellar technologies, to develop, manufacture, distribute and sell JOTROL.
Follow-Up Questions
Qui est le CEO de Jupiter Neurosciences Inc ?
Mr. Christer Rosen est le Chairman of the Board de Jupiter Neurosciences Inc, il a rejoint l'entreprise depuis 2016.
Quelle est la performance du prix de l'action JUNS ?
Le prix actuel de JUNS est de $1.25, il a increased de 0.39% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Jupiter Neurosciences Inc ?
Jupiter Neurosciences Inc appartient à l'industrie Pharmaceuticals et le secteur est Health Care
Quel est la capitalisation boursière de Jupiter Neurosciences Inc ?
La capitalisation boursière actuelle de Jupiter Neurosciences Inc est de $43.7M
Est-ce que Jupiter Neurosciences Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 3 analystes ont établi des notations d'analystes pour Jupiter Neurosciences Inc, y compris 2 achat fort, 4 achat, 1 maintien, 0 vente et 2 vente forte